{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:46:56Z","timestamp":1792806416647,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-025-00390-x","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:34:09Z","timestamp":1760013249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the cardiotoxicity risk based on the HFA-ICOS score in a group of sub-Saharan African women before breast cancer treatment by chemotherapy and\/or radiotherapy: a cross-sectional study in a group of Cameroonian women"],"prefix":"10.1186","volume":"11","author":[{"given":"Chris Nad\u00e8ge","family":"Nganou-Gnindjio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne Atenguena","family":"Okobalemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic Alban","family":"Tasong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude Marl\u00e8ne","family":"Zende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules Thierry","family":"Elong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Tumtchou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthe Esson","family":"Mapoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junie Annick","family":"Metogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Essiben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e2","family":"Hamadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"390_CR1","first-page":"101332","volume":"50","author":"C Belger","year":"2023","unstructured":"Belger C, Abrahams C, Imamdin A, Lecour S. Doxorubicin-induced cardiotoxicity and risk factors. Int J Cardiol Heart Vasc. 2023;50:101332.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"390_CR2","unstructured":"Derni\u00e8res statistiques. mondiales sur le cancer \u2013 GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 \u2013 IARC."},{"issue":"7","key":"390_CR3","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.18203\/2320-1770.ijrcog20172898","volume":"6","author":"F Essiben","year":"2017","unstructured":"Essiben F, Foumane P, Meka EJ, Tchakount\u00e9 M, Dohbit JS, Nsahlai C, et al. Descriptive analysis of 192 cases of breast cancer occurring before age 40 in Yaounde, Cameroon. Int J Reprod Contracept Obstet Gynecol. 2017;6(7):2704\u201310.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"9","key":"390_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/14740338.2017.1351541","volume":"16","author":"S Martel","year":"2017","unstructured":"Martel S, Maurer C, Lambertini M, Pond\u00e9 N, De Azambuja E. Breast cancer treatment-induced cardiotoxicity. Expert Opin Drug Saf. 2017;16(9):1021\u201338.","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"390_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ancard.2022.07.007","volume":"71","author":"A Jagu","year":"2022","unstructured":"Jagu A. \u00ab Que Doit savoir Un cardiologue Sur Le suivi et La prise En charge d\u2019une femme Atteinte de cancer du sein? \u00bb. Ann De Cardiologie Et d\u2019Ang\u00e9iologie. 2022;71(5):304\u201308.","journal-title":"Ann De Cardiologie Et d\u2019Ang\u00e9iologie"},{"key":"390_CR6","doi-asserted-by":"crossref","unstructured":"Zbinden S, B\u00fchlmann M, Aebi S, Suter T. Effets ind\u00e9sirables cardiovasculaires du traitement m\u00e9dicamenteux moderne du cancer. Forum M\u00e9d Suisse \u2013 Swiss Med Forum. 2010;10(08).","DOI":"10.4414\/fms.2010.07095"},{"issue":"2","key":"390_CR7","doi-asserted-by":"publisher","first-page":"ehac5442591","DOI":"10.1093\/eurheartj\/ehac544.2591","volume":"43","author":"B Rivero Santana","year":"2022","unstructured":"Rivero Santana B, Caro Codon J, Juarez Olmos V, Martinez Monzonis A, Zatarain-Nicolas E, Moliner P, et al. HFA-ICOS cardiovascular toxicity risk score validation in CARDIOTOX registry. Eur Heart J. 2022;43(2):ehac5442591.","journal-title":"Eur Heart J"},{"issue":"5","key":"390_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.banm.2020.10.018","volume":"205","author":"N Frikha","year":"2021","unstructured":"Frikha N, Chlif M. Un aper\u00e7u des facteurs de risque du cancer du sein. Bull Acad\u00e9mie Natl M\u00e9decine. 2021;205(5):519\u201327.","journal-title":"Bull Acad\u00e9mie Natl M\u00e9decine"},{"key":"390_CR9","unstructured":"Alouani CE, Tahri A. Etude prospective de La cardiotoxicit\u00e9 des anthracyclines [Th\u00e8se de doctorat]. Faculte de Medecine et de Pharmacie universit\u00e9 CADI AYYAD; 2010."},{"issue":"2","key":"390_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12558-010-0060-x","volume":"2","author":"A Togo","year":"2010","unstructured":"Togo A, Traor\u00e9 A, Traor\u00e9 C, Demb\u00e9l\u00e9 BT, Kant\u00e9 L, Diakit\u00e9 I, et al. Cancer du Sein Dans Deux centres hospitaliers de Bamako (Mali): aspects diagnostiques et th\u00e9rapeutiques. J Afr Cancer Afr J Cancer. 2010;2(2):88\u201391.","journal-title":"J Afr Cancer Afr J Cancer"},{"key":"390_CR11","unstructured":"Farsi A, Kouadri N. Profil \u00e9pid\u00e9miologique, pathologique et \u00e9volutif du cancer du Sein Chez La femme de Sud Alg\u00e9rien 2015\u20132020. Universit\u00e9 Kasdi Merbah Ouargla; 2022."},{"key":"390_CR12","unstructured":"Seydou F. Cancer du sein chez la femme de moins de 50 ans: profil epidemiologique et aspects anatomopathologiques au centre hospitalier universitaire gabriel toure de bamako. j sago Gyn\u00e9cologie \u2013 Obst\u00e9trique Sant\u00e9 Reprod. 2022;23(1)."},{"issue":"2","key":"390_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.32604\/oncologie.2022.021250","volume":"24","author":"O Som\u00e9","year":"2022","unstructured":"Som\u00e9 O, Bagu\u00e9 A, Konkobo D, Hien D, Demb\u00e9l\u00e9 A, B\u00e9lemlilga GL, et al. Le cancer du Sein \u00e0 Bobo-Dioulasso, Burkina faso: r\u00e9sultats de La prise En charge. Oncologie. 2022;24(2):173\u201384.","journal-title":"Oncologie"},{"issue":"12","key":"390_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s10269-009-1823-9","volume":"11","author":"Recommandations pour la pratique clinique","year":"2009","unstructured":"Recommandations pour la pratique clinique. Nice, Saint-Paul de Vence 2009 \u00ab cancers du Sein \u00bb et \u00ab Soins de support \u00bb: partie II \u2014 Soins de support. Oncologie. 2009;11(12):612\u2013793.","journal-title":"Oncologie"},{"issue":"12","key":"390_CR15","first-page":"1017","volume":"98","author":"I Bouhlel","year":"2020","unstructured":"Bouhlel I, Chabchoub I, Hajri E, Ernez S, Gouider J. Early screening of cardiotoxicity of chemotherapy by echocardiography and myocardial biomarkers. Tunis Med. 2020;98(12):1017\u201323.","journal-title":"Tunis Med"},{"key":"390_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijcard.2021.11.059","volume":"349","author":"G Tini","year":"2022","unstructured":"Tini G, Cuomo A, Battistoni A, Sarocchi M, Mercurio V, Ameri P, et al. Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: the HFA\/ICOS risk tool in real-world practice. Int J Cardiol. 2022;349:134\u20137.","journal-title":"Int J Cardiol"},{"key":"390_CR17","doi-asserted-by":"crossref","unstructured":"Hequet O, Le Q, Moullet I, Pauli E, Salles G, Espinouse D et al. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol. 2004;22(10).","DOI":"10.1200\/JCO.2004.06.033"},{"issue":"26","key":"390_CR18","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1200\/JCO.2016.67.4846","volume":"34","author":"C Guenancia","year":"2016","unstructured":"Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, et al. Obesity as a risk factor for anthracyclines and trastuzumab cardiotoxicity in breast cancer: a systematic review and meta-analysis. J Clin Oncol. 2016;34(26):3157.","journal-title":"J Clin Oncol"},{"key":"390_CR19","doi-asserted-by":"crossref","unstructured":"Kabor\u00e9 EG, Guenancia C, Vaz-Luis I, Meglio AD, Pistilli B, Coutant C et al. Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study. PLoS Med. 2019;16(12).","DOI":"10.1371\/journal.pmed.1002989"},{"key":"390_CR20","first-page":"200153","volume":"15","author":"LJ Philip","year":"2022","unstructured":"Philip LJ, Findlay SG, Gill JH. Baseline blood pressure and development of cardiotoxicity in patients treated with anthracyclines: a systematic review. Int J Cardiol Cardiovasc Risk Prev. 2022;15:200153.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00390-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-025-00390-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00390-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:34:14Z","timestamp":1760013254000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-025-00390-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1186\/s40959-025-00390-x","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Ethical Review Board of the Universit\u00e9 des Montagnes (Cameroon) approved the study, and the ethics clearance number 2024\/037\/UdM\/PR\/CEAQ was obtained. Before the survey, we received authorisation number 092\/24\/AP\/MINSANTE\/SG\/DHCY\/CM\/SM from the Yaounde Central Hospital and authorisation number 192\u2009\u2212\u200924\/HGY\/DG\/DPM\/APM-TR from the Yaounde General Hospital. We also received free, informed and signed consent from the various participants. The data used in this study were anonymised before use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}